WEBULL
WebtradeDownload

Core Scientific Stock Earnings Turnaround Has The Bull Case Changed

Simply Wall St · 2d ago
  • Core Scientific reported third quarter 2026 revenue of US$232.87 million and net income of US$1.18b, compared with revenue of US$81.1 million and a net loss of US$144.03 million in the same period a year earlier.
  • The swing from a basic loss per share of US$0.45 a year ago to basic earnings per share of US$3.42 highlights how much of Core Scientific's current story rests on accounting effects and capital structure, not just operations.
  • In the sections that follow, we will look at how Core Scientific's investment narrative is reshaped by this sharp revenue jump and the shift to quarterly profitability.

Scan beyond Core Scientific's headline swing in earnings and compare it with other crypto and blockchain plays moving on fresh results by reviewing the 23 cryptocurrency and blockchain stocks.

Core Scientific Investment Narrative Recap

To own Core Scientific, you need to believe the colocation and digital asset infrastructure business can convert contracted power and hosting demand into durable cash generation, despite a complex balance sheet. The latest quarter shows revenue of US$232.87 million and reported net income of about US$1.18b, but much of that profit is tied to non cash warrant gains rather than day to day activity.

The near term catalyst still sits where DanielOliveira, an investor in the Simply Wall St Community, puts it: around how Texas capacity at Pecos and Hunt is resolved and timed. Earnings for the first nine months still show a net loss of US$324.37 million and negative equity plus less than one year of cash runway, so execution on these data center projects and funding needs remains the key operational risk.

DanielOliveira, a Simply Wall St Community investor who wrote the narrative, argues that ERCOT decisions on the Texas data center allocations for AMD linked sites could matter more for Core Scientific than any single quarter of results. Those contracts, covering hundreds of megawatts, frame whether the existing colocation footprint becomes a platform for larger scale AI and high density compute tenants.

The Q3 revenue beat and high adjusted EBITDA margins cited by DanielOliveira came from capacity that is already billing. The next phase depends on Texas approvals and construction execution. Against a backdrop of negative shareholders equity, limited cash runway and a volatile share price, progress on Denton, Pecos and Hunt looks central to how investors weigh upside from contracted megawatts against financing and regulatory setbacks.

The narrative values Core Scientific at US$12.76 per share, based on the view that ERCOT keeping allocations for Pecos and Hunt intact would confirm the AMD linked megawatt contracts as fully credible long term cash engines. DanielOliveira argues that this justifies a higher mark for the existing contracted load.

Uncover how Core Scientific's fair value indicates a 12% potential downside to its current price, a premium that may not be sustained.

NasdaqGS:CORZ 1-Year Stock Price Chart
NasdaqGS:CORZ 1-Year Stock Price Chart

Exploring Other Perspectives

One alternate view on Core Scientific focuses less on Texas power allocations and more on customer concentration risk. Before this earnings release, the lowest analysts were working off revenue forecasts of about US$1.8b and potential earnings of roughly US$220.7 million by 2029, which presents a more cautious earnings path. Those projections were set without the latest quarterly numbers, so some of those pessimistic models may be updated as new data comes through. That gap in expectations shows how sharply opinions can diverge, so it can help to compare several narratives and decide which assumptions you find most reasonable.

Explore 2 other Core Scientific fair value estimates, including one that suggests it could be worth just $27.24!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Looking for more investment ideas beyond Core Scientific?

Once you have formed a view on Core Scientific, it can help to compare it with other opportunities that match your risk tolerance and income goals. The Simply Wall St Screener lets you filter the market quickly so you spend time assessing businesses, not just hunting for tickers.

  • If capital preservation matters most to you, start with stocks that currently score well on balance sheet strength and fundamentals through this list of solid balance sheet and fundamentals (23 results).
  • For investors hunting for quality at a sensible price, consider companies that combine strong financials with valuations flagged as potentially attractive using the 32 high quality undervalued stocks.
  • Those who value stability and regular cash returns can focus on opportunities with higher yields and resilient payout histories by reviewing the 6 dividend fortresses.